T0	KEYPHRASE-NOTYPES 3 11	contrast
T1	KEYPHRASE-NOTYPES 15 51	post-treatment Lyme disease syndrome
T2	KEYPHRASE-NOTYPES 53 73	chronic Lyme disease
T3	KEYPHRASE-NOTYPES 79 97	controversial term
T4	KEYPHRASE-NOTYPES 110 132	considerable confusion
T5	KEYPHRASE-NOTYPES 152 180	standardized case definition
T6	KEYPHRASE-NOTYPES 213 222	existence
T7	KEYPHRASE-NOTYPES 224 233	Ingeneral
T8	KEYPHRASE-NOTYPES 248 259	individuals
T9	KEYPHRASE-NOTYPES 281 289	symptoms
T10	KEYPHRASE-NOTYPES 295 320	persistent Lyme infection
T11	KEYPHRASE-NOTYPES 321 333	irrespective
T12	KEYPHRASE-NOTYPES 345 353	theyhave
T13	KEYPHRASE-NOTYPES 356 363	history
T14	KEYPHRASE-NOTYPES 367 379	Lyme disease
T15	KEYPHRASE-NOTYPES 381 413	Multiple patient advocacy groups
T16	KEYPHRASE-NOTYPES 435 443	patients
T17	KEYPHRASE-NOTYPES 462 478	negative results
T18	KEYPHRASE-NOTYPES 525 543	chronic infections
T19	KEYPHRASE-NOTYPES 588 599	individuals
T20	KEYPHRASE-NOTYPES 615 629	second opinion
T21	KEYPHRASE-NOTYPES 654 662	disorder
T22	KEYPHRASE-NOTYPES 669 675	groups
T23	KEYPHRASE-NOTYPES 695 710	guide lines
T24	KEYPHRASE-NOTYPES 719 729	management
T25	KEYPHRASE-NOTYPES 733 753	chronic Lyme disease
T26	KEYPHRASE-NOTYPES 755 761	Others
T27	KEYPHRASE-NOTYPES 775 785	physicians
T28	KEYPHRASE-NOTYPES 791 811	sufficient knowledge
T29	KEYPHRASE-NOTYPES 818 830	Lyme disease
T30	KEYPHRASE-NOTYPES 869 875	assays
T31	KEYPHRASE-NOTYPES 893 902	diagnosis
